Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry
Abstract
Anti-PVRIG and anti-TIGIT antibodies are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.
We use essential cookies to run TraceComp (e.g. to remember a report you've unlocked) and,
with your consent, analytics/advertising cookies. See our Privacy Policy.
